Cargando…

Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018

Previously reported associations between hospital-level antibiotic use and hospital-onset Clostridioides difficile infection (HO-CDI) were reexamined using 2012–2018 data from a new cohort of US acute-care hospitals. This analysis revealed significant positive associations between total, third-gener...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kazakova, Sophia V., Baggs, James, Yi, Sarah H., Reddy, Sujan C., Hatfield, Kelly M., Guh, Alice Y., Jernigan, John A., McDonald, L. Clifford
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Concise Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346446/ https://www.ncbi.nlm.nih.gov/pubmed/33958010 http://dx.doi.org/10.1017/ice.2021.151

Ejemplares similares

Association of Hospital-Onset Clostridium difficile Infection Rates and Antibiotic Use in US Acute Care Hospitals, 2006–2012: An Ecologic Analysis
por: Kazakova, Sophia, et al.
Publicado: (2017)

2891. Trends in Inpatient Antibiotic Use in US Hospitals, 2012–2017
por: Baggs, James, et al.
Publicado: (2019)

Role of diagnostic stewardship in reducing healthcare-facility–onset Clostridioides difficile infections
por: Shallal, Anita B., et al.
Publicado: (2023)

24. Antibiotic Use in Hospital Emergency Departments and Observation Settings from 2012–2018 in a Large Cohort of U.S. Hospitals
por: Preston, Leigh Ellyn, et al.
Publicado: (2020)

2314. Hospitalizations and Antibiotic Use in the Year Prior to an Incident C. difficile Infection for Medicare Beneficiaries in Four States, 2016–2018
por: Hatfield, Kelly M, et al.
Publicado: (2022)

121. Temporal Trends in Urine Culture Rates in the U.S. Acute Care Hospitals During 2012–2017
por: Kazakova, Sophia, et al.
Publicado: (2020)

The accuracy of fully automated algorithms for surveillance of healthcare-onset Clostridioides difficile infections in hospitalized patients
por: van der Werff, Suzanne Desirée, et al.
Publicado: (2022)

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
por: Yi, Sarah H, et al.
Publicado: (2018)

545. Incidence of Carbapenem Non-Susceptible Acinetobacter spp. and Carbapenem-Resistant Pseudomonas aeruginosa Clinical Cultures among Patients in US Acute Care Hospitals, 2012–2017
por: Kazakova, Sophia, et al.
Publicado: (2019)

Temporal trends in urine-culture rates in the US acute-care hospitals, 2017–2020
por: Kazakova, Sophia, et al.
Publicado: (2022)

Examining the impact of racial disparities on Clostridioides difficile infection outcomes at a Southern California academic teaching hospital
por: Lee, Jina M., et al.
Publicado: (2023)

837. Prior Hospitalizations Among Cases of Community-Associated Clostridioides difficile Infection—10 US States, 2014–2015
por: Hatfield, Kelly M, et al.
Publicado: (2019)

916. National Estimates of the Proportion of Bacterial Pathogens Expressing Resistant Phenotypes in US Hospitals, 2012-2017
por: Baggs, James, et al.
Publicado: (2020)

845. Trends and Regional Differences in Community-Onset Fluoroquinolone-Resistant E. coli in Hospitalized Adults in the United States
por: Wolford, Hannah, et al.
Publicado: (2020)

1686. Microbiology of Community-Onset Urinary Tract Infections in the United States, 2012-2017
por: Preston, Leigh Ellyn, et al.
Publicado: (2020)

Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
por: Dysangco, Andrew T., et al.
Publicado: (2022)

Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent Clostridioides difficile infection in US hospitals
por: Scott, R. Douglas, et al.
Publicado: (2019)

Minimizing the risk of Clostridioides difficile infection as an early complication of autologous stem cell transplantation
por: Van Galen, Joseph, et al.
Publicado: (2023)

147. Opportunities for Improving Urine Culturing Practices in U.S. Acute Care Hospitals, 2017-2020
por: Asonganyi, Nyawung, et al.
Publicado: (2023)

Optimizing the interpretation of Clostridioides difficile two-step diagnostic algorithm results through antimicrobial stewardship
por: Lowe, Christopher F., et al.
Publicado: (2022)

780. How Much Does Prior Hospitalization Contribute to Readmission with Community-onset Clostridioides difficile Infection?
por: Guh, Alice, et al.
Publicado: (2020)

Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022
por: Hatfield, Kelly M., et al.
Publicado: (2023)

Molecular epidemiology of Clostridioides difficile isolates in a non-outbreak setting at a comprehensive cancer center
por: Mehta, Neha, et al.
Publicado: (2023)

2479. Trends and Regional Differences in Extended Spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, 2012–2017
por: Wolford, Hannah, et al.
Publicado: (2019)

427. Trends in Hospital-onset Escherichia coli Infections Resistant to Fluoroquinolones and Extended-spectrum Cephalosporins, 2012-2020
por: Hood, Nicole, et al.
Publicado: (2022)

Community-Onset Clostridioides Difficile Infection in Hospitalized Patients in The Netherlands
por: Crobach, M J T, et al.
Publicado: (2019)

Nurse Work Environment and Hospital-Onset Clostridioides difficile Infection
por: Jung, Olivia S., et al.
Publicado: (2023)

Hospital-onset Clostridioides difficile infections during the COVID-19 pandemic
por: Luo, Yuying, et al.
Publicado: (2020)

Length of antibiotic therapy among adults aged ≥65 years hospitalized with uncomplicated community-acquired pneumonia, 2013-2020
por: McCarthy, Natalie, et al.
Publicado: (2023)

2463. Increased Rates of Candida Bloodstream Infections Associated with Drug Use, United States 2012–2017
por: McCarthy, Natalie, et al.
Publicado: (2019)

2413. Assessment of compliance with Clostridioides difficile prophylaxis guideline and its efficacy on secondary prophylaxis and reducing hospital-onset Clostridioides difficile infections.
por: Vyas, Nikunj M, et al.
Publicado: (2019)

Mitigating hospital-onset Clostridioides difficile: The impact of an optimized environmental hygiene program in eight hospitals
por: Carling, Philip C., et al.
Publicado: (2023)

Impacts of Corticosteroid Therapy at Acute Stage of Hospital-Onset Clostridioides difficile Infections
por: Lee, Ching-Chi, et al.
Publicado: (2022)

1203. Impact of Antimicrobial Stewardship Interventions on Hospital-Onset Clostridioides difficile Infections
por: Kwon, Taesung, et al.
Publicado: (2023)

Pediatric surgical site infections in 287 hospitals in the United States, 2015–2018
por: Mathew, Roshni, et al.
Publicado: (2023)

Declines in the utilization of hospital‐based care during COVID‐19 pandemic
por: Kazakova, Sophia V., et al.
Publicado: (2022)

Role of diagnostic stewardship in reducing healthcare facility-onset Clostridioides difficile infections
por: Shallal, Anita, et al.
Publicado: (2022)

Ribotyping of Clostridioides difficile in the Liberec Regional Hospital: a tertiary health care facility
por: Kracík, Martin, et al.
Publicado: (2022)

1428. The proportion of excess hospital-onset antibiotic-resistant infections attributable to patients diagnosed with COVID-19 in U.S. hospitals, 2019-2021
por: Wolford, Hannah, et al.
Publicado: (2023)

Clostridioides difficile Is Not Difficult to Predict in Hospital Settings
por: Alexander, Kinta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v1h6tak3am6v4qgs80gkui3peu